AI Article Synopsis

  • Inflammation is significant in type 2 diabetes, but the role of rosiglitazone in skeletal muscle inflammation has not been thoroughly investigated.
  • A study using OLETF diabetic rats showed that rosiglitazone treatment led to lower serum glucose and insulin levels, as well as reduced inflammatory cytokines over time.
  • The findings indicate that rosiglitazone may enhance insulin sensitivity and exert anti-inflammatory effects on skeletal muscle in type 2 diabetes.

Article Abstract

Background: Inflammation plays a role in the response to metabolic stress in type 2 diabetes. However, the effects of rosiglitazone on inflammation of skeletal muscle have not been fully examined in type 2 diabetes.

Methods: We investigated the effects of the insulin-sensitizing anti-diabetic agent, rosiglitazone, on the progression of skeletal muscle inflammation in Otsuka Long-Evans Tokushima Fatty (OLETF) type 2 diabetic rats. We examined the expression of serologic markers (serum glucose, insulin and free fatty acid) and inflammatory cytokines (tumor-necrosis factor-alpha, interleukin [IL]-1beta and IL-6) in OLETF rats from early to advanced diabetic stage (from 28 to 40 weeks of age).

Results: Serum glucose and insulin concentrations were significantly decreased in rosiglitazone-treated OLETF rats compared to untreated OLETF rats. Rosiglitazone treatment significantly decreased the concentrations of serum inflammatory cytokines from 28 to 40 weeks of age. The mRNA expression of various cytokines in skeletal muscle was reduced in rosiglitazone-treated OLETF rats compared with untreated OLETF rats. Furthermore, rosiglitazone treatment resulted in the downregulation of ERK1/2 phosphorylation and NF-kappaB expression in the skeletal muscle of OLETF rats.

Conclusion: These results suggest that rosiglitazone may improve insulin sensitivity with its anti-inflammatory effects on skeletal muscle.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898933PMC
http://dx.doi.org/10.4093/kdj.2010.34.3.191DOI Listing

Publication Analysis

Top Keywords

skeletal muscle
20
oletf rats
20
effects rosiglitazone
8
rosiglitazone inflammation
8
inflammation otsuka
8
otsuka long-evans
8
long-evans tokushima
8
tokushima fatty
8
serum glucose
8
glucose insulin
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!